Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: CSR

Falcon.io Announces It Will Provide Free Services to Global Health Organizations, Following an Initiative Led by Messenger

In response to the COVID-19 crisis, Falcon.io will offer complimentary services

COPENHAGEN, March 27, 2020 /PRNewswire/ -- Falcon.io, a Cision company, announced it will participate in a global initiative that Messenger from Facebook launched this week, in response to COVID-19. The program connects government health organizations and UN health agencies with developers that can assist them in leveraging the Messenger platform to more effectively share timely and accurate information, and speed up their responses to concerned citizens.

"As is common in any crisis, people are using digital channels like Messenger to stay connected and get information from trusted health authorities that are on the front lines fighting this global pandemic," Messenger said in a statement announcing the initiative. "To that end, we're launching a global program to connect government health organizations and UN health agencies with developers that can help them use Messenger most effectively to share timely and accurate information, and speed up their responses to concerned citizens. Our developer partners have offered to provide their services free of charge to these organizations during this crisis."

Falcon.io is proud to announce it will be one of Messenger's technology providers in this effort, and will offer services free of charge to those organizations looking for additional support during the crisis. Falcon.io's complimentary offering includes the complete usage of Falcon.io's Essentials Base+ solution with unlimited users. This will help organizations:

In addition, the Falcon.io Marketing and Product teams will be hosting a portfolio of content with tutorials, as well as webinars, to help these organisations manage their social media strategy and teams. More information can be found here.

"Falcon.io is proud to support Messenger with this global initiative and provide solutions to organizations particularly in need right now," said Ulrik Bo Larsen, President of Cision Social & Founder and CEO of Falcon.io.

"It is important to us that business leaders and technology providers join forces to combat this crisis as a united force. I'm humbled that our solutions can be of value, and we're happy to help technology leaders like Messenger enable organisations globally to do their part."

For more information about the program, please visit

About Falcon.io
Falcon.io offers an integrated SaaS platform for social media listening, engaging, publishing, advertising, analytics and benchmarking. The company enables its clients to explore the full potential of digital marketing by managing multiple customer touchpoints from one platform. Its client portfolio includes Carlsberg, Toyota, William Grant & Sons, momondo, Panasonic and Coca-Cola. For more information, please visit www.falcon.io.

About Cision
Cision Ltd. is a leading global provider of earned media software and services to public relations and marketing communications professionals. Cision's software allows users to identify key influencers, craft and distribute strategic content, and measure meaningful impact. Cision has over 4,800 employees with offices in 24 countries throughout the Americas, EMEA, and APAC. For more information about its award-winning products and services, including the Cision Communications Cloud®, visit www.cision.com and follow Cision on Twitter @Cision.

Media Contacts:
Rebecca Dersh
PR Manager, Cision

Natasha Adams
VP of Marketing, Falcon.io


Photo - https://mma.prnewswire.com/media/1138261/Falcon_x_Messenger.jpg

Logo - https://mma.prnewswire.com/media/974326/Falcon_io_Logo.jpg

These press releases may also interest you

at 11:23
Today, Samaritan's Purse deployed its Emergency Field Hospital to New York City, New York, where the local medical infrastructure is severely overwhelmed. In cooperation with the Federal Emergency Management Agency (FEMA), New York state officials,...

at 11:01
Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was...

at 11:00
As the impact of the Coronavirus (COVID-19) is now felt worldwide, we want to assure our customers and partners that we are still here to support you. Zenner's operations remain open with regular operating hours. Zenner's number one priority is...

at 10:13
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg...

at 10:05
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the VICTORIA trial, a Phase 3 study evaluating the efficacy and safety of its investigational drug vericiguat, an orally administered soluble...

at 10:00
Amgen today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK (BEIJERINCK) study evaluating the efficacy and safety of Repatha® (evolocumab) in...

News published on 27 march 2020 at 04:00 and distributed by: